Immunoreactivity of the 14F7 Mab raised against N-glycolyl GM3 ganglioside in primary lymphoid tumors and lymph node metastasis

Pathology Research International

Volumn 2013, Issue , 2013, Pages

  Blanco, Rancés ^a   Blanco, Damián ^b   Quintana, Yisel ^a   Escobar, Xiomara ^b   Rengifo, Charles E ^c   Osorio, Marta ^b   Gutiérrez, Zailí ^b   Lamadrid, Janet ^b   Cedeño, Mercedes ^a   Frómeta, Milagros ^a   Carr, Adriana ^a   Rengifo, Enrique ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^b INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^c Hospital Manuel Fajardo   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893694151     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2013/920972     Document Type: Article

References (45)

1. El-Sayed A. M., El-Borai M. H., Bahnassy A. A., El-Gerzawi S. M. S., Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry. Diagnostic Pathology 2008 3 1, article 43 2-s2.0-62349115160 10.1186/1746-1596-3-43
2. Berthold D., Ghielmini M., Treatment of malignant lymphoma. Swiss Medical Weekly 2004 134 33-34 472 480 2-s2.0-4644339191
3. Weng J., Rawal S., Chu F., Park H. J., Sharma R., Delgado D. A., Fayad L., Fanale M., Romaguera J., Luong A., Kwak L. W., Neelapu S. S., TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood 2012 120 8 1613 1623 10.1182/blood-2011-09-382838
4. Walk E. L., Weed S. A., Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma. Cancers 2011 3 1 747 772 2-s2.0-79953699977 10.3390/cancers3010747
5. DiSibio G., French S. W., Metastatic patterns of cancers: results from a large autopsy study. Archives of Pathology and Laboratory Medicine 2008 132 6 931 939 2-s2.0-45549109634
6. Yamashita T., Wada R., Sasaki T., Deng C., Bierfreund U., Sandhoff K., Proia R. L., A vital role for glycosphingolipid synthesis during development and differentiation. Proceedings of the National Academy of Sciences of the United States of America 1999 96 16 9142 9147 2-s2.0-0033529760 10.1073/pnas.96.16.9142
7. Vazquez A. M., Alfonso M., Lanne B., Karlsson K., Carr A., Barroso O., Fernandez L. E., Rengifo E., Lanio M. E., Alvarez C., Zeuthen J., Perez R., Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides that also recognizes sulfated glycolipids. Hybridoma 1995 14 6 551 556 2-s2.0-0029586061
8. Carr A., Mullet A., Mazorra Z., Vázquez A. M., Alfonso M., Mesa C., Rengifo E., Pérez R., Fernández L. E., A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 2000 19 3 241 247 2-s2.0-0033624355 10.1089/02724570050109639
9. Osorio M., Gracia E., Rodríguez E., Saurez G., Arango M. D. C., Noris E., Torriella A., Joan A., Gómez E., Anasagasti L., González J. L., Melgares M. D. L. A., Torres I., González J., Alonso D., Rengifo E., Carr A., Pérez R., Fernández L. E., Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a phase Ib/IIa study. Cancer Biology and Therapy 2008 7 4 488 495 2-s2.0-45349091152
10. Blanco R., Rengifo E., Cedeño M., Rengifo C. E., Alonso D. F., Carr A., Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 ganglioside in epithelial malignant tumors from digestive system. ISRN Gastroenterology 2011 2011 8 645641 10.5402/2011/645641
11. van Cruijsen H., Ruiz M., van der Valk P., de Gruijl T. D., Giaccone G., Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. BMC Cancer 2009 9, article 180 2-s2.0-67650394884 10.1186/1471-2407-9- 180
12. Scursoni A. M., Galluzzo L., Camarero S., Lopez J., Lubieniecki F., Sampor C., Segatori V. I., Gabri M. R., Alonso D. F., Chantada G., de Dávila M. T. G., Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. Clinical and Developmental Immunology 2011 2011 6 2-s2.0-81555226715 10.1155/2011/245181 245181
13. Scursoni A. M., Galluzzo L., Camarero S., Pozzo N., Gabri M. R., de Acosta C. M., Vázquez A. M., Alonso D. F., de Dávila M. T. G., Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry. Pediatric and Developmental Pathology 2010 13 1 18 23 2-s2.0-77949739944 10.2350/08-10-0544.1
14. Blanco R., Rengifo E., Rengifo C. E., Cedeño M., Frómeta M., Carr A., Immunohistochemical reactivity of the 14F7 monoclonal antibody raised against N-glycolyl GM3 ganglioside in some benign and malignant skin neoplasms. ISRN Dermatology 2011 2011 8 848909 10.5402/2011/848909
15. Blanco R., Cedeño M., Escobar X., Blanco D., Rengifo C. E., Frómeta M., Alvarez R. I., Rengifo E., Carr A., Immunorecognition of the 14F7 Mab raised against N-Glycolyl GM3 ganglioside in some normal and malignant tissues from genitourinary system. ISRN Pathology 2011 2011 10 953803 10.5402/2011/953803
16. Blanco R., Rengifo C. E., Cedeño M., Frómeta M., Rengifo E., Carr A., Immunoreactivity of the 14F7 MAb (raised against N-glycolyl GM3 ganglioside) as a positive prognostic factor in non-small cell lung cancer. Pathology Research International 2012 2012 12 235418 10.1155/2012/235418
17. Blanco R., Quintana Y., Blanco D., Cedeño M., Rengifo C. E., Frómeta M., Ríos M., Rengifo E., Carr A., Tissue reactivity of the 14F7 MAb raised against N-glycolyl GM3 ganglioside in tumors of neuroectodermal, mesodermal and epithelial origin. Journal of Biomarkers Journal of Biomarkers 2013 2013 9 602417 10.1155/2013/602417
18. Zhong Y., Wu Y., Li C., Tang J., Wang X., Ren G., Carr A., Pérez R., Guo W., N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese. Oral Diseases 2012 18 8 741 747 10.1111/j.1601-0825.2012. 01939.x
19. Vázquez A. M., Pérez A., Hernández A. M., Macías A., Alfonso M., Bombino G., Pérez R., Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody. Hybridoma 1998 17 6 527 534 2-s2.0-0032412454
20. Roque-Navarro L., Chakrabandhu K., de León J., Rodríguez S., Toledo C., Carr A., de Acosta C. M., Hueber A., Pérez R., Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity. Molecular Cancer Therapeutics 2008 7 7 2033 2041 2-s2.0-51049099189 10.1158/1535-7163.MCT-08-0222
21. Schwarz A., Futerman A. H., Determination of the localization of gangliosides using anti-ganglioside antibodies: comparison of fixation methods. Journal of Histochemistry and Cytochemistry 1997 45 4 611 618 2-s2.0-0030964873
22. Alonso D. F., A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma. International Journal of Oncology 1999 15 1 59 66 2-s2.0-0033163316
23. Hayashi N., Chiba H., Kuronuma K., Go S., Hasegawa Y., Takahashi M., Gasa S., Watanabe A., Hasegawa T., Kuroki Y., Inokuchi J., Takahashi H., Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody. Cancer Science 2013 104 1 43 47 10.1111/cas.12027
24. Anh-Tuan N., Pick J., Mod A., Hollan S. R., Gangliosides in acute myeloid leukaemia (AML) and non-Hodgkin's lymphoma (NHL). European Journal of Cancer and Clinical Oncology 1986 22 8 1003 1007 2-s2.0-0022474837
25. O'Boyle K. P., Freeman K., Kalisiak A., Agregado A., Scheinberg D. A., Patterns of ganglioside expression in B cell neoplasms. Leukemia and Lymphoma 1996 21 3-4 255 266 2-s2.0-0029969346
26. Higashi H., Nishi Y., Fukui Y., Ikuta K., Ueda S., Kato S., Fujita M., Nakano Y., Taguchi T., Sakai S., Tumor-associated expression of glycosphingolipid Hanganutziu-Deicher antigen in human cancers. Gann 1984 75 11 1025 1029 2-s2.0-0021686074
27. Malykh Y. N., Schauer R., Shaw L., N-glycolylneuraminic acid in human tumours. Biochimie 2001 83 7 623 634 2-s2.0-0034844959 10.1016/S0300-9084(01) 01303-7
28. Tangvoranuntakul P., Gagneux P., Diaz S., Bardor M., Varki N., Varki A., Muchmore E., Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid. Proceedings of the National Academy of Sciences of the United States of America 2003 100 21 12045 12050 2-s2.0-0142059844 10.1073/pnas. 2131556100
29. Bardor M., Nguyen D. H., Diaz S., Varki A., Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. The Journal of Biological Chemistry 2005 280 6 4228 4237 2-s2.0-14244266499 10.1074/jbc.M412040200
30. Nishimaki T., Kano K., Milgrom F., Hanganutziu-Deicher antigen and antibody in pathologic sera and tissues. Journal of Immunology 1979 122 6 2314 2318 2-s2.0-0018379273
31. Higashi H., Naiki M., Matuo S., Okouchi K., Antigen of "serum sickness" type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochemical and Biophysical Research Communications 1977 79 2 388 395 2-s2.0-0017665490
32. Nguyen D. H., Tangvoranuntakul P., Varki A., Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells. Journal of Immunology 2005 175 1 228 236 2-s2.0-21244478903
33. Kawai T., Kato A., Higashi H., Kato S., Naiki M., Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Research 1991 51 4 1242 1246 2-s2.0-0025752614
34. Kanduma E. G., Mukuria J. C., Mwanda O. W., Serum total sialic acid and Hanganutziu-Deicher antibody in normals and in cancer patients. East African Medical Journal 2007 84 5 207 214 2-s2.0-34547438902
35. Carr A., Rodríguez E., Arango M. D. C., Camacho R., Osorio M., Gabri M., Carrillo G., Valdés Z., Bebelagua Y., Pérez R., Fernández L. E., Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine. Journal of Clinical Oncology 2003 21 6 1015 1021 2-s2.0-0037445114 10.1200/JCO.2003.02.124
36. Osorio M., Gracia E., Reigosa E., Hernandez J., de la Torre A., Saurez G., Perez K., Viada C., Cepeda M., Carr A., Avila Y., Rodríguez M., Fernandez L. E., Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma. Cancer Management and Research 2012 4 341 345 10.2147/CMAR.S22617
37. Pérez K., Osorio M., Hernández J., Carr A., Fernández L. E., NGcGM3/VSSP vaccine as treatment for melanoma patients. Human vaccines and immunotherapeutics 2013 9 6 1237 1240 10.4161/hv.24115
38. Lauc G., Heffer-Lauc M., Shedding and uptake of gangliosides and glycosylphosphatidylinositol-anchored proteins. Biochimica et Biophysica Acta 2006 1760 4 584 602 2-s2.0-33646083938 10.1016/j.bbagen.2005.11.014
39. McKallip R., Li R., Ladisch S., Tumor gangliosides inhibit the tumor-specific immune response. Journal of Immunology 1999 163 7 3718 3726 2-s2.0-0033213878
40. Birklé S., Zeng G., Gao L., Yu R. K., Aubry J., Role of tumor-associated gangliosides in cancer progression. Biochimie 2003 85 3-4 455 463 2-s2.0-0038532523 10.1016/S0300-9084(03)00006-3
41. + regulatory T cells function. International Immunology 2008 20 4 591 600 2-s2.0-41149148210 10.1093/intimm/dxn018
42. Cochran A. J., Huang R., Lee J., Itakura E., Leong S. P. L., Essner R., Tumour-induced immune modulation of sentinel lymph nodes. Nature Reviews Immunology 2006 6 9 659 670
43. Carr A., Mesa C., Arango M. D. C., Vázquez A. M., Fernández L. E., In vivo and in vitro anti-tumor effect of 14F7 monoclonal antibody. Hybridoma and Hybridomics 2002 21 6 463 468 2-s2.0-0037716989
44. Zhiqiang A., Antibody Therapeutics-a mini review. Trends in Bio/Pharmaceutical Industry 2008 2 24 29
45. Fernández-Marrero Y., Roque-Navarro L., Hernández T., Dorvignit D., Molina-Pérez M., González A., Sosa K., López-Requena A., Pérez R., de Acosta C. M., A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates. Immunobiology 2001 16 12 1239 12347 10.1016/j.imbio.2011.07.004